News Releases

SenesTech's Evolve™ Fertility Control Solution for Rats To Be Deployed in the U.S. Virgin Islands

PHOENIX, June 26, 2024 – SenesTech, Inc. (Nasdaq: SNES; “SenesTech” or the “Company”), the leader in fertility control to manage animal pest populations, today announced that EvolveTM, the Company’s minimum risk soft bait for the proactive control of rats, will be trialing the product in the U.S Virgin Islands as an effort to show new and innovative programs to control pest outside traditional measures. This effort is administered by the Wild Ecology Group.

“The Wild Ecology Group is optimistic that Evolve can be implemented as part of a long term, sustainable solution to invasive species.  The trial will be initiated in a handful of the territory’s some 60 islands” said Nick Morrison of the Wild Ecology Group. “Ultimately, we are very happy to begin this partnership with Senestech and excited to see the results of this innovative product; Evolve.”

“The initial multi-pallet order is already en route to the U.S. Virgin Islands, and we have reserved The Wild Ecology’s regular order in our production schedule,” said Joel Fruendt, the President and CEO of SenesTech.

Evolve addresses the fundamental issue of rodent overpopulation by focusing on their rapid reproduction rates. Evolve proactively controls the population by reducing the rodent fertility, rather than trying to keep up with the growing numbers of an infestation with poisons alone. The active ingredient in Evolve has been shown to effectively reduce fertility in rodents in numerous independent studies. Evolve is highly palatable, easy to deploy, and offers diverse placement in many different environments.

About SenesTech

SenesTech is committed to improving the health of the world by humanely managing animal pest populations through fertility control. The company is an expert in fertility control to manage animal pest populations. SenesTech invented ContraPest, the only U.S. EPA-registered contraceptive for male and female rats, and Evolve, an EPA-designated minimum-risk contraceptive currently offered for rats. ContraPest and Evolve fit seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management. SenesTech strives for clean cities, efficient businesses and happy households–with a product designed to be humane, effective and sustainable.

For more information, visit https://senestech.com/.

Safe Harbor Statement

This press release contains “forward-looking statements” within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, among others, our belief that Evolve is a paradigm shift in pest control. Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as “believe,” “may,” “future,” “plan,” “will,” “should,” “expect,” “anticipate,” “eventually,” “project,” “estimate,” “continuing,” “intend” and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the successful commercialization of our products; market acceptance of our products; our financial performance, including our ability to fund operations; our ability to regain and maintain compliance with Nasdaq’s continued listing requirements; regulatory approval and regulation of our products; and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2023. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

CONTACT:  
Investors:
Robert Blum, Lytham Partners, LLC,
602-889-9700, senestech@lythampartners.com

Company:
Tom Chesterman, Chief Financial Officer, SenesTech, Inc.,
928-779-4143 x825